Optimizing the clinical management of <i>EGFR</i>-mutant advanced non-small cell lung cancer: a literature review.

Transl Lung Cancer Res · 2022 · PMC9186167 · PMID 35693274

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the subgroup analysis, former-smoker (HR 0.481) and patients with Ex19del (HR 0.622) showed a trend toward a not significant increase of PFS in favour of the combination arm, as previously observed in other similar studies ( 56 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.